• Question: Does visual augmentation (3D color visualization) enhance learning and performance during central venous access in a mixed reality procedural simulator? • Findings: Automatically generated performance scores improved significantly with real-time or delayed visualization.
T he supraclavicular approach to the subclavian vein (first described by Yoffa 1 in 1965) has a shorter distance and less tissue to traverse before access to the vein compared to the more familiar infraclavicular technique. The supraclavicular approach provides a larger cross-sectional area of the vein as a target, a larger margin of safety from accidental violation of the pleura, a lower rate of malpositioning, and some evidence of fewer complications. [2] [3] [4] Complications include arterial puncture and pneumothorax. 2 The largest barrier to adoption of the supraclavicular approach in clinical practice is likely the lack of familiarity compared to the internal jugular, femoral vein, or infraclavicular access to the subclavian.
The University of Florida central venous access (CVA) mixed reality simulator facilitates practice in learning to access the internal jugular and subclavian central veins. 5 This mixed reality simulator allows real-time or delayed 3D visualization of the needle's location inside soft tissue structures within a mannequin's virtual anatomy displayed on a computer screen while also providing tactile feedback for nondeformable (bony) structures on a modular anatomical block ( Figure 1 ). The CVA simulator has a built-in automated scoring algorithm based on contact with or proximity to the lung/arteries/trachea, time to venous access, number of attempts, and number of skin punctures. Training with a task trainer enhanced acquiring and retaining clinical skills related to aseptic placement of central venous catheters. [6] [7] [8] [9] Using a mixed reality simulator may not only provide a risk-free environment for training but also facilitate successful training for accessing the subclavian vein via the supraclavicular approach.
The hypotheses were as follows: (1) Three-dimensional visualization of internal structures improves the efficacy of simulation for trainees learning how to access a central vein and (2) real-time 3D visualization during a trainee's CVA attempt is superior to delayed 3D visualization playback.
METHODS
Participants were randomized into either the real-time visualization group (RTVG), with concurrent 3D visualization with their first attempt, or the delayed visualization group (DVG), with 3D visualization playback of their second attempt. Comparisons were made between the 2 group's scores for each attempt to investigate potential relationships.
The simulator used for the study is a turnkey, mixed reality simulator for practicing, learning, teaching, and debriefing CVA by the internal jugular, infraclavicular, supraclavicular, and axillary approaches with and without ultrasound (US) guidance. For more information, see Figure 1 and videos: http://simulation.health.ufl.edu/ research/cva_sim.mp4 and https://www.youtube.com/ watch?v=0lTIFbiiwRs.
The simulator uses mixed reality via an anatomically authentic, 3D-printed physical mannequin based on a computed tomographic scan of an actual human and a corresponding 3D virtual model of the anatomy of the neck and upper chest. Hand-held instruments such as a needle, an US probe, and a virtual camera controller are directly manipulated by the trainee and tracked and recorded with submillimeter resolution via miniature, 6 degrees of freedom magnetic sensors. 10 An automated scoring algorithm and a replay system allow self-debriefing. 10, 11 Furthermore, the user can practice US-guided CVA by orientating the needle and the US probe out-of-plane or in-plane with reference to one another.
Study Protocol
After Institutional Review Board approval and informed consent, volunteers (anesthesia trainees, emergency medicine trainees, and attending anesthesiologists) at the University of Florida took part in a study with the CVA simulator in performing the supraclavicular approach to the subclavian vein. Enrollment of participants was combined with 2 other studies evaluating participants' ability to access the internal jugular vein with simulated US and to access the subclavian vein using an infraclavicular approach. Individuals were free to refuse to take part in the study and were also excluded from analysis if they only wanted to receive training for CVA.
Participants completed a prestudy questionnaire to provide demographic data, including level of training, prior experience, and self-rated confidence in the ability to perform the supraclavicular approach. This was followed by a brief video that oriented them to the features of the CVA simulator and provided instructions on how to use it. All participants also received scripted instructions (video and text, but not verbal) on how to perform a supraclavicular approach. In addition, all participants had prior experience with the CVA simulator's elements while attempting to access the subclavian vein using the infraclavicular approach and the internal jugular vein with US before their first attempt at accessing the subclavian vein using the supraclavicular approach. Participants were then randomly assigned to one of 2 groups, the RTVG or the DVG. Neither group used US imaging for the supraclavicular approach to the subclavian vein. As shown in Figure 2 , the RTVG was allowed to concurrently use real-time 3D visualization of soft tissue structures inside the simulator while performing venous access only for their first attempt (trial 1); the DVG performed the procedure 3 times, all without realtime 3D visualization. Participants were denied access to the real-time 3D visualization (displayed on the screen of a generic laptop computer running the simulator) by using the virtual camera controller to change the perspective of the virtual camera away from the virtual patient.
Participants in the DVG performed their initial attempt (trial 1) without real-time 3D visualization, which ended either with successful access or after 5 minutes had elapsed. This attempt was scored by the simulator's automated scoring algorithm. Participants were then allowed to rewatch the scripted video or reread the written instructions. Participants in the DVG were then given a second attempt (without real-time 3D visualization). Afterward, delayed 3D visualization of the DVG participant's second attempt (trial 2) was played back to the participant with an instructor present. Afterward, participants in the DVG were given a third attempt without real-time 3D visualization, which was also scored. The third attempt (trial 3) was to test our second hypothesis (see Figure 2 ) on whether real-time 3D visualization was superior to delayed 3D visualization playback after an attempt. The comparison between the final attempt in the DVG (trial 3) and RTVG (trial 2) evaluates each group's attempt immediately after their use of the 3D visualization and the participant's ability to access the vein based on information acquired from the 3D visualization.
Participants randomized to the RTVG watched the same instructional video and received the same written instructions as the DVG after the video orientation to the simulator. The participants from the RTVG were asked to access the subclavian vein via the supraclavicular approach while using the real-time 3D visualization of the simulator. Participants were then allowed to rewatch the video or reread the written instructions on how to access the subclavian vein using the supraclavicular approach. Afterward, RTVG participants performed a second attempt but without real-time 3D visualization.
An automated scoring algorithm is integrated into the simulator. The algorithm generates an objective numerical score by applying penalties associated with errors and potential complications such as pneumothorax, arterial puncture, back-walling the vein, too many needle passes, and taking too much time. Incidents that cause significant injury, such as arterial punctures and pneumothoraces, incur larger penalties, whereas lesser penalties are applied to less serious events such as taking too much time, backwalling the vein, or taking extra attempts. Unsafe nearmisses are also penalized, that is, coming dangerously close to the artery or lung incurs penalties scaled to how close the needle tip came to causing injury. Penalties may be applied to needle trajectories outside predefined safe and acceptable zones ("cones of safety") that are specific to the type of approach for attaining CVA. Recorded CVA attempts from experts as well as substandard performance examples were used to tune the scoring algorithm. All attempts for both groups were scored. All participants completed a poststudy questionnaire and were debriefed.
Statistical Analysis
SAS, version 9.4 (SAS Institute, Cary, NC), was used for data analysis. Descriptive statistics, reported in Table 1 , were calculated for baseline characteristics for the RTVG, DVG, and for all participants. Because the score distributions for the RTVG and DVG were negatively skewed and nonnormal, as assessed by the Shapiro-Wilk test (W; P < .0001), nonparametric statistical methods were used for analysis. The difference in algorithm scores for each participant between trial 1 and the final trial (trial 2 for RTVG and trial 3 for DVG) was calculated, and the Wilcoxon 2-sample rank sum test (equivalent to the Mann-Whitney U statistic) was used to test whether improvement in performance was dependent on group. Between-group differences were tested on the algorithm score on trial 1 (RTVG1 versus DVG1) and www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA 3D Visualization Improves CVA Training trial 2 (RTVG2 versus DVG2), and for final attempts (trial 2 for RTVG versus trial 3 for DVG). The Wilcoxon rank sum test was also used to test group differences on the computed difference variables (RTV1 − RTV2) versus (DV1 − DV2) and (RTV1 − RTV2) versus (DV1 − DV3). The Wilcoxon rank sum test does not assume that the difference between 2 independent samples is normally distributed or that the population variances are equal. 12 The Hodges-Lehman estimator was computed for the difference in medians and 95% confidence intervals (CIs) for the median difference. 12, 13 The Wilcoxon signed rank test was used to determine if there was a significant improvement in scores between trials within each group. All statistical tests were 2 tailed, and the significance level was set at α = .05.
The data collected on the supraclavicular approach were part of a larger study investigating additional approaches to CVA where in addition to group (RTVG versus DVG), a second between-subjects factor, level of training with 3 levels, was being studied. Based on our previous work with simulation for CVA, this study was planned for power = 0.80, assuming a 2-tailed test with significance level, α = .05, a modest correlation between trials for the repeated measures (ρ = 0.20) to detect a moderately large effect size (ie, 0.60 in standard deviation [SD] units) for the CVA algorithm score. A priori power analysis suggested that 10 participants in each cell are sufficient to achieve target power (60 participants randomly assigned to visualization group by level of training). However, because only 2 participants reported any exposure to the supraclavicular approach, the level of training was not a factor and post hoc power analysis based on the visualization factor alone suggests that 28 participants in each group are sufficient to attain target power (N = 56).
RESULTS
Results are based on participants with signed informed consent and complete data (N = 69). The algorithm score range is from 0 to 600. The scores of 3 anesthesiologist coauthors (J.W.S., W.B.S., and A.R.R.), with a combined clinical experience of 25 years in CVA and all comfortable with the supraclavicular approach to the subclavian vein before the initiation of the study, for 3 attempts each at the supraclavicular approach without visualization yielded a mean of 578 and a median of 572. Although scores were reduced by errors and near-misses as described above, most participants lost points in the scoring algorithm due to the time penalty alone. As a result, score distributions were negatively skewed. Reported in Table 2 are descriptive statistics (medians, interquartile range, and 95% CIs for the medians), as well as the results of our hypothesis tests (Wilcoxon rank sum statistic, S, P values, the Hodges-Lehman estimator for the difference in medians, and 95% CIs for the median difference). Supplemental Digital Content, Figure 1 , http:// links.lww.com/AA/C84, shows a graphical representation of all the scores, which shows very little variation unless participants had a complication.
There was no difference in performance gains (trial 1 -trial 2) between the RTVG and the DVG (P = .70). The difference between the first trial (trial 1 for both groups) and the final trial (trial 2 for the RTVG and trial 3 for the DVG) was also not dependent on group (P = .41) as seen in Table 2 .
Since the RTVG had 3D visualization while the DVG did not, there was a significant difference in performance between the groups at trial 1 (P = .01). The Hodges-Lehman estimator for the median difference with 95% CI is 10.20 (2.2-23.1). As hypothesized, there was also a significant difference in performance observed at trial 2 (P = .007). The group that received real-time visualization during trial 1 performed better than the group that would receive delayed visualization before trial 3. The estimated median difference and 95% CI is 10.75 (3.4-20.9). There was no difference in performance between the 2 groups on their final trial (trial 2 for RTVG and trial 3 for DVG), P = .13. The estimated median difference and 95% CI is 4.2 (−0.8 to 11.4).
Within-group comparisons show that for the RTVG, given the score range with a high score of 600, performance was extremely high for both attempts (medians for trial 1 = 584.8 versus trial 2 = 590.2). The difference in performance between trial 1 and trial 2 is not significant (P = .08). This suggests that high scores were produced on trial 1, with real-time 3D visualization available, and that the scores remained high on the second trial when visualization was not available to participants. For the DVG, there was no difference between trial 1 versus trial 2 (P = .24), both without visualization. Thus, there was no improvement in performance after a second attempt without 3D visualization. After viewing the delayed 3D visualization of their performance on trial 2 for the DVG, performance was significantly better on trial 3 when compared to trial 1 (P = .0007), but not for trial 3 versus trial 2 (P = .17).
Only 2 of the 69 participants reported that they had ever used the supraclavicular approach for central line placement. Despite this lack of familiarity, only 1 participant (DVG group) failed to access the subclavian vein on the first trial. All participants, regardless of group assignment (with or without real-time visualization), successfully accessed the subclavian vein on their final trial. Three participants required >1 attempt to access the vein (2, 6, and 8 attempts) on trial 1; only 1 participant needed >1 attempt on their last trial. Table 3 reports overall complications and scoring penalties. In addition to the participants who caused a pneumothorax, 3 additional participants received a penalty in the scoring algorithm for coming "close" (<1 cm from the lung) to causing a pneumothorax on trial 1 and 3 on their final trial. There was no overlap in these errors (the participants causing pneumothorax were not the same). Study participants also completed surveys before and immediately after the simulator session; results reported in Table 4 show relevant items. Participants were overwhelmingly positive about simulator training for the supraclavicular approach to subclavian vein access both as an educational tool for trainees and as an aid to improve their own technical proficiency. Participants were also asked to rate their confidence in performing the supraclavicular approach for subclavian vein CVA pre-and posttraining on a 10-point scale where 1 = "not at all confident" and 10 = "completely confident." Not surprisingly, given the fact that only 2 participants reported any previous experience with this technique, on average, the confidence for all participants before training was 1.6 (SD = 1.1). Mean posttraining confidence rating was 7.2 (SD = 1.8). The median for the confidence gain scores, 6.0 (interquartile range = 3.0), was significantly >0 (Wilcoxon signed rank test, S = 11.39, P < .0001). Although confidence gains in the RTVG (median = 6.0) were greater than in the DVG (median = 5.0), the Wilcoxon rank sum test shows that this difference was not significant, S = 876.5, P = .08.
DISCUSSION
The original motivation for this study was to evaluate the learning outcomes and efficacy of a new mixed reality procedural simulator. This research was part of a larger study to investigate the efficacy of a mixed reality simulator with and without visual augmentation (real-time, 3D, and color visualization) for teaching various approaches to CVA. No statistically significant differences in performance between the 2 groups due to real-time 3D visualization were identified when comparing the gain scores between the first and last trials for each group (hypothesis 2). Despite not finding a significant benefit afforded by real-time 3D visualization compared to delayed 3D visualization, on average, participants improved significantly in their ability to successfully access the subclavian vein via the supraclavicular approach after interacting with the simulator. This finding is similar to the improvement found in other task trainers. [5] [6] [7] [8] [9] The availability of real-time 3D visualization was associated with significantly higher scores for the RTVG on attempt 1 compared to the DVG attempt 1. Although the comparison of the 2 groups on the gain score between trial 1 and trial 2 was not significant (P = .70), the algorithm scores for the RTVG remained significantly higher than the hDVG on trial 2 (even though the RTVG no longer had access to visualization), P = .007. These results indicate that the benefits of exposure to the real-time visualization (possibly in forming a 3D mental model of the relevant anatomy for the supraclavicular approach) may have been retained and that a second attempt alone is not enough to optimize performance. Our findings indicate that 3D visualization is helpful in improving performance as measured by the scores, irrespective of whether the visualization was in real time or delayed, supporting our first hypothesis.
Users of the CVA procedural simulator reported a significant improvement in their self-rated confidence in supraclavicular access to the subclavian vein. This is very encouraging given the fact that only 2 participants reported any prior experience with the supraclavicular technique. This study is also, for most participants, their only exposure to the supraclavicular approach to the subclavian vein. With only 2-3 attempts by each participant, the CVA simulator, in combination with scripted video instructions, was able to show subjective evidence of the improvement in confidence, as well as a low complication rate (most penalties were from a time delay). This would suggest that the supraclavicular approach to the subclavian vein is a relatively easy procedure to learn and that simulation improved the participant's performance and their confidence in attempting it.
The findings of the study show a floor and ceiling effect for the algorithm scores. Providers may be uncomfortable accessing the subclavian using the supraclavicular approach because they never trained with it, but US imaging may increase a provider's confidence. Because US was not used in the referenced literature, it was not used in this study. However, using US guidance may help further improve confidence and decrease the potential for complications with the supraclavicular approach.
The safety and teachability of the supraclavicular approach were not the premises of this study, and as such, further study would be necessary to evaluate the supraclavicular approach compared to the infraclavicular approach. This approach may be advantageous in patients with a cervical collar in place and concomitant thoracic injuries and those undergoing cardiopulmonary resuscitation. Although the reason the infraclavicular approach is relatively more popular is not known, it may be because it was described earlier in the literature.
2 This is despite its high complication rate and the longer distance that needs to be traversed percutaneously to actually access the subclavian vein via the subclavian approach.
The Kirkpatrick 14 evaluation model has 4 levels where each level builds on the previous one. Assessment of adoption of training into daily clinical practice (Kirkpatrick level 3) as well as the directly attributable effect of the training on patient outcomes (Kirkpatrick level 4) are eventual goals of our research, but are beyond the scope of this article. The study we describe is at Kirkpatrick level 2 (learning outcomes). In a methodical process where each step builds on the previous Kirkpatrick level in a crawl, walk, run progression, we purposely limited our initial approach to a learning outcome study. The learning outcome study is needed to establish that training with the simulator improves learning to enable us to approach our hospital administration (and other educators) with hard evidence that may be of help in convincing our management that the 3D visualizationbased training should be provided to all relevant clinical personnel. For all questions in Table 2 , there were no responses that were not 4 or 5.
a Response options for these questions evaluating the simulator training used a scale with 5 response options: 1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree.
CONCLUSIONS
The CVA simulator was efficacious for training clinicians to access the subclavian vein using the supraclavicular approach that was, for most participants, unfamiliar. The use of real-time 3D visualization during an access attempt showed significantly improved scores compared to the group without 3D visualization. Training with the CVA simulator did not prevent errors in technique, nor were significant differences found in using real-time 3D visual augmentation (visualization) while performing access attempts versus playing back prior attempts using delayed 3D visualization. More studies are necessary to determine whether the improved scores resulting from visual augmentation are clinically significant and will translate into better patient outcomes. Additional studies are needed to establish if the use of US imaging can decrease the complication rate with the supraclavicular approach in both simulated and actual clinical settings. E DISCLOSURES Name: Joshua Warren Sappenfield, MD.
